Dogwood TherapeuticsDWTX
13F holders, Q1 2026 (March 31)13holders +3
4new positions
2sold out
$2.11avg. 13F price*
At the end of Q1 2026, 13 institutions reported holding Dogwood Therapeutics Inc. (DWTX) in their 13F filings, up 3 from Q4 2025. 4 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($6.9M), Vanguard Capital Management LLC ($279K) and Geode Capital Management, LLC ($168K).
- Company
- Dogwood Therapeutics Inc.
- CUSIP
- 92829J203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $7.0M |
| Exits | 2 | $41K |
All 13F filers, Q4 2025 → Q1 2026: 3,394,537 shares bought and 9,892 shares sold, net +3,384,645 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Armistice Capital, LLC | 0.23% | New | 3,280,000 | $6.9M |
| Vanguard Capital Management LLC | 0.00% | — | 132,154 | $279K |
| Geode Capital Management, LLC | 0.00% | Add +373.4% | 79,434 | $168K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 62,736 | $132K |
| Northern Trust Corp. | 0.00% | New | 23,779 | $50K |
| Goldman Sachs Group Inc. | 0.00% | New | 14,598 | $31K |
| Marshall Wace, LLP | 0.00% | Add +0.9% | 11,756 | $25K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 8,067 | $17K |
| UBS Group AG | 0.00% | Add +305.3% | 7,085 | $15K |
| Activest Wealth Management | 0.00% | No change | 120 | $253 |
| BlackRock, Inc. | 0.00% | No change | 30 | $63 |
| Group One Trading LLC | 0.00% | No change | 9 | $19 |
| BNP Paribas Financial Markets | 0.00% | No change | 2 | $4 |
"% of holder's portfolio" is DWTX's weight in each manager's 13F, not the share of Dogwood Therapeutics Inc. the manager owns.